Best Startup
At Best Startup UK we track over 130,000 UK startups and over 500,000 people who hold key positions in these companies. We use this directory of startups to highlight top employees, founders and board members we think deserve more appreciation than they are currently getting.
This list showcases the top United Kingdom based VP’ operating in the Life Science space. If you think a VP’ is missing from this list, feel free to contact our editor on editor@beststartup.co.uk.
The individuals on this list have been included because of exceptional performance in one of the following categories:
- Innovation – Operating as a key part in an extremely innovative business or startup.
- Growth – Operating as a key figure in the growth and upscale of a market leading business or startup.
- Management – Showing exceptional management skills.
- Societal impact – Putting their business on the map for their positive societal or environmental impact.
Our Data – We source our data from OSINT (open source intelligence) and public directories such as Companies House UK, Crunchbase, SemRush and many more. The data from these sources should be treated with a degree of caution and verified yourself.
Alun McCarthy
Vice President of C4X Discovery
Alun has over 30 years of pharmaceutical industry experience, including drug discovery & development, genetics and biomarker research. Alun was co-founder and CEO of both Adorial (in 2014) and of PGXIS (in 2007). Former roles at GlaxoSmithKline include Head of Translational Medicine & Genetics for Psychiatry, Director of Clinical Pharmacogenetics, and Medical Strategy Head for CV/Metabolic Diseases. Alun has managed staff on a global basis, and has significant experience of engaging with regulatory authorities in the US, Europe and Japan. He holds a BA (Biochemistry) from the University of Cambridge, and a PhD (Biochemistry) from Trinity College, Dublin.
Follow Alun McCarthy:
About C4X Discovery: C4X Discovery brings a new dimension to drug discovery. Using its unique NMR-based technique to determine 3D molecular.
Martin Watson
Vice President of C4X Discovery
Martin was one of the first employees of the Company, coming from AstraZeneca plc where he had worked for 4 years in the industrial application of NMR to drug discovery. He has a first class masters chemistry degree from the University of Birmingham and a PhD from the University of Sheffield. He has applied NMR techniques across a wide range of drug targets.
Follow Martin Watson:
About C4X Discovery: C4X Discovery brings a new dimension to drug discovery. Using its unique NMR-based technique to determine 3D molecular.
Stella Blackburn
VP, Global Head of Early Access & Risk Management & Real World Evidence Solutions of IQVIA
Follow Stella Blackburn:
About IQVIA, London School of Hygiene & Tropical Medicine: IQVIA is a global provider of advanced analytics, technology solutions and contract research services to the life sciences industry.
Andrew Lonergan
VP Sales and Marketing of Aspect Imaging
Follow Andrew Lonergan:
About Aspect Imaging: World leader in the design and manufacture of compact, high-performance MRI & NMR systems offering Complete Point-of-Care MRI systems
Paul Lyons
Vice President of Platform Delivery & Co-Founder of PredictImmune
Paul is a Principal Research Associate in the Department of Medicine at the University of Cambridge. He has over 25 years of experience in molecular and cellular biology including Senior Scientist positions in the Dept. Medical Genetics, University of Cambridge, Dept. Surgery, University of Oxford and the Rosalind Franklin Centre for Genomics Research. His primary research interest is the application of high throughput genomic approaches to better understand the genetic and molecular basis of autoimmune disease.
Follow Paul Lyons:
About PredictImmune: Providing tools to physicians in the treatment of patients with immune-mediated disease, through prediction of long term clinical prognosis.
Giles Snare
Vice President , Sales Developed Markets of Beckman Coulter
Follow Giles Snare:
About Beckman Coulter: Beckman Coulter develops, manufactures and markets products that simplify & automate biomedical testing for lab professionals.
Tony Brown
Vice President of Scientific and Corporate Development of Asterand
Tony has been with Asterand Bioscience for 16 years. Prior to taking up his current position, he held a number of senior positions within the company including General Manager for the UK Services business, General Manager for the Detroit-based tissue products business and VP, Strategic Alliances, with responsibility for securing and managing the Company’s human tissue supply collaborations. Tony began his career teaching physiology at Nottingham University Medical School in the UK, after obtaining degrees in engineering, bioengineering and a PhD in physiology. He subsequently joined SmithKline Beecham in 1988, where he headed up the receptor pharmacology group within neurosciences research, and led several drug discovery projects and drug screening programs. Tony joined Pharmagene (now Asterand Bioscience) in 1998. Tony has published on the pharmacology and biochemistry of ion and neurotransmitter transport and on the use of human tissues for research in drug discovery and development.
Follow Tony Brown:
About Asterand: Asterand Bioscience is the leading global provider of high quality, well characterized human tissue & human tissue-based research solution.
Nicholas Lakin
Vice President, Advisory Services of Kinapse
Follow Nicholas Lakin:
About Kinapse: Kinapse provides advisory, capability building and operational services to the life sciences industries.
